Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases

Overview of attention for article published in Frontiers in immunology, June 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 9 news outlets

twitter: 2 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 29 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 14 news stories from 9 outlets.

Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA (inebilizumab) as a Monotherapy for the Treatment of Adult Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)

MarketScreener, 15 Nov 2021

DUBLIN - (Nasdaq: HZNP) announced that the Committee for Medicinal Products for Human Use (CHMP) of the (EMA) has adopted a…

Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA (inebilizumab) as a Monotherapy for the Treatment of Adult Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)

FirstWord Pharma, 12 Nov 2021

-- CHMP recommendation based on positive results from N-MOmentum, the largest clinical trial ever conducted in NMOSD to date -- …

News story from Finanz Nachrichten on Friday 12 November 2021

Finanz Nachrichten, 12 Nov 2021

News story from Finanz Nachrichten on Friday 12 November 2021

Finanz Nachrichten, 12 Nov 2021

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 10 additional news stories.